WHITNEY PRUITT: Open Payments
NPI 1104543545 · SHALLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 55 payments from 16 companies in 2025. Trend: 2023 $1,486 · 2024 $926 · 2025 $1,115
Food & beverage: $1,095Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $255 |
| ABBVIE INC. | 8 | $136 |
| AstraZeneca Pharmaceuticals LP | 4 | $135 |
| Lilly USA, LLC | 6 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $100 |
| Amgen Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Corcept Therapeutics | 3 | $50 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
Products named: Wegovy, MOUNJARO, Kerendia, VRAYLAR, AIRSUPRA, CAPLYTA, Korlym, OTEZLA.
Industry payments across NC — which companies pay providers there.
